CLOV vs ZTS · rev $1.37B vs P/E 25, rev $9.47B
Clover Health Investments Corp (CLOV) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ZTS revenue for 2025-12-31 was $9.47B. Net income was $2.67B. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
CLOV currently screens at market cap $1.55B. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the CLOV and ZTS stock pages for the full models.
Not investment advice.